If these metabolic features prove to be diagnostic, I have very little problem with them being downstream effects - if that is indeed the case. That it begs the obvious causal question can be placed on the back burner for a short spell to celebrate.
I also have concerns the findings may not prove peculiar to ME, but they are offset by hopes that they will.
I want to know the cause, but for now I will be very happy with a solid and representative characterization of ME/CFS for the huge advance it appears to be - especially if the cause is secondary to the effect. Kudos, Team Stanford. The cheer for the day is Replicate, Replicate, Replicate.
After hoisting a well-earned beer. Or two.